Jaiswal Pharma’s Post

Vildagliptin IP tablets, branded as Galvus 50mg, are highly effective for managing type 2 diabetes. They help regulate blood sugar levels by inhibiting the DPP-4 enzyme, which increases insulin production and decreases glucose production in the liver. This ensures better glycemic control, reduces HbA1c levels, and enhances overall health. Ideal for patients seeking effective and reliable diabetes management. #DiabetesCare #BloodSugarControl #Galvus50mg #Type2Diabetes #HealthyLiving #Vildagliptin #GlycemicControl #JaiswalPharma #PharmaBag #WholesaleMedicine #PharmaWholesale #MedicineDistributor #HealthcareSupplyChain #PharmaLogistics #PharmacyWholesale #MedicalSupplies #DrugDistribution #HealthcareDistributor #PharmaSuppliers #PharmaceuticalSuppliers #MedSupplyChain #Biocon #Glenmark #PharmaBusiness #DrugWholesale #SunPharma #Cipla #DrReddys #LupinPharma #AurobindoPharma #NovartisIndiaLtd #Valdast-m

To view or add a comment, sign in

Explore topics